Tagged cornea

Press Release

Holland Foundation for Sight Restoration Announces Partnership With Mass Eye and Ear

Third Holland Foundation Center of Excellence To Be Established

 Read More
Holland Foundation for Sight Restoration Announces Second Annual Ocular Surface Stem Cell Transplantation Education Conference
Press Release

Holland Foundation for Sight Restoration Announces Second Annual Ocular Surface Stem Cell Transplantation Education Conference

 Read More
Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema
Press Release

Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema

 Read More
Ophthalmic Industry Leader Erin Schallhorn Powers Joins Holland Foundation for Sight Restoration Board of Directors
Press Release

Ophthalmic Industry Leader Erin Schallhorn Powers Joins Holland Foundation for Sight Restoration Board of Directors

 Read More
Eye Love Rock N’ Roll Benefit Concert to Support Holland Foundation for Sight Restoration at ASCRS
Press Release

Eye Love Rock N’ Roll Benefit Concert to Support Holland Foundation for Sight Restoration at ASCRS

 Read More
Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a Phase 2/3 Clinical Trial Evaluating Nexagon for the Treatment of Persistent Corneal Epithelial Defects
Press Release

Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a Phase 2/3 Clinical Trial Evaluating Nexagon for the Treatment of Persistent Corneal Epithelial Defects

 Read More
Amber Ophthalmics Announces Positive Topline Phase 2 Data Evaluating NEXAGON® for the Treatment of Persistent Corneal Epithelial Defect (PCED)
Press Release

Amber Ophthalmics Announces Positive Topline Phase 2 Data Evaluating NEXAGON® for the Treatment of Persistent Corneal Epithelial Defect (PCED)

 •• Complete epithelial recovery was achieved by 67% of subjects receiving NEXAGON, as opposed to 27% receiving Vehicle alone •• NEXAGON was well-tolerated demonstrating a safety profile similar to vehicle •• Amber plans to initiate the NEXPEDE-1 Phase 2/3 clinical trial in subjects with PCED of various etiologies in Q1 2023 •• Read More
The Animal Eye Institute Announces a New Location in Charleston, South Carolina
Press Release

The Animal Eye Institute Announces a New Location in Charleston, South Carolina

 Read More
Wilmington Eye Welcomes New Cornea Specialist in Wilmington
Press Release

Wilmington Eye Welcomes New Cornea Specialist in Wilmington

 With the addition of a cornea specialist, patients will have increased access to specialty vision care, improving overall healthcare outcomes for the community Read More
Press Release

Ophthalmologist Named Top Doctor

 In September, Dr. Nauheim was named to the Consumers' Research Council of America "Guide to America's Top Ophthalmologists" for the third consecutive year. Read More
Press Release

International Stem Cell Corporation's Parthenogenetic Stem Cell Patent Approved by the United States Patent and Trademark Office

 International Stem Cell Corporation announced that the United States Patent and Trademark Office has granted ISCO a patent relating to the company's development of human non-embryonic parthenogenetic stem cells. Human parthenogenetic stem cells are Read More